Table 7.
Chemotherapy regimen in black versus white patients.
| Treatment | Black N (%) | White N (%) | Total | Chi-square (p-value) |
|---|---|---|---|---|
| All | 473 | 252 | 725 | |
| Chemotherapy1 | 0.40 | |||
| Taxane-containing | 227 (87.98%) | 110 (90.91%) | 337 | |
| No taxane | 31 (12.02%) | 11 (9.09%) | 42 | |
| All Treatments | <0.01 | |||
| Chemo | 278 (58.77%) | 107 (42.46%) | 385 | |
| Chemo + Endocrine | 143 (30.23%) | 118 (46.83%) | 261 | |
| Chemo + Trastuzumab | 21 (4.44%) | 8 (3.17%) | 29 | |
| Chemo + Endocrine + Trastuzumab | 31 (6.55%) | 19 (7.54%) | 50 |
1
Detailed chemotherapy information missing from 428 patients: Black N=258; Adjuvant, N=121